Moderna (MRNA) Interest Coverage Ratio (2018 - 2026)
Moderna's (MRNA) quarterly Interest Coverage Ratio came in at 3.62 in Q1 2026, down 284.84% year-on-year from 1.96 in Q1 2025, and down 12.9% on a QoQ basis from 3.21 in Q3 2025.
Moderna (MRNA) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Moderna (MRNA) has 9 years of Interest Coverage Ratio data on file, last reported at 3.62 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 284.84% year-over-year to 3.62 in Q1 2026; TTM through Mar 2026 was 8.91, a 166.37% decrease from a year earlier, with the FY2025 full-year figure at 14.43, down 1028.21% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 3.62, down from 3.21 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for MRNA reached as high as 23.75 in Q1 2022 and fell as low as 3.62 in Q1 2026.
- Historically, Interest Coverage Ratio has averaged 1.64 across 5 years, with a median of 0.61 in 2025.
- Across the five-year window, Interest Coverage Ratio soared 6744.67% in 2022 and tumbled 15075.7% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 10.19 in 2022, then sank by 99.97% to 0.0 in 2023, then tumbled by 15075.7% to 0.4 in 2024, then slumped by 694.48% to 3.21 in 2025, then retreated by 12.9% to 3.62 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 3.62 in Q1 2026, 3.21 in Q3 2025, and 0.82 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | -3.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.62 |
| Sep 30, 2025 | -3.21 |
| Jun 30, 2025 | -0.82 |
| Mar 31, 2025 | -0.94 |
| Dec 31, 2024 | -0.40 |
| Sep 30, 2024 | -0.06 |
| Jun 30, 2024 | -1.16 |
| Mar 31, 2024 | -1.07 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | -1.18 |
| Jun 30, 2023 | -1.11 |
| Mar 31, 2023 | -0.22 |
| Dec 31, 2022 | 10.19 |
| Sep 30, 2022 | 4.32 |
| Jun 30, 2022 | 1.83 |
| Mar 31, 2022 | 23.75 |
| Dec 31, 2021 | 36.31 |
| Sep 30, 2021 | 3.56 |
| Jun 30, 2021 | 0.47 |
| Mar 31, 2021 | 0.35 |